News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
753,548 Results
Type
Article (53794)
Company Profile (457)
Press Release (699297)
Section
Business (216925)
Career Advice (2855)
Deals (37243)
Drug Delivery (120)
Drug Development (86784)
Employer Resources (184)
FDA (17109)
Job Trends (15898)
News (368231)
Policy (35521)
Tag
2024 BioCapital Digital (10)
2024 BioForest Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Digital (9)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (9)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (19)
2024 Biotech Beach Digital (10)
2024 Biotech Beach Standard (7)
2024 Genetown Digital (8)
2024 Genetown Standard (11)
2024 Lone Star Bio Digital (9)
2024 Pharm Country Digital (8)
2024 Pharm Country Standard (7)
2025 BioForest Digital (4)
2025 Lone Star Bio Digital (8)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (1)
Academia (2911)
Academic (1)
Accelerated approval (3)
Adcomms (27)
Allergies (87)
Alliances (53089)
ALS (93)
Alzheimer's disease (1461)
Antibody-drug conjugate (ADC) (133)
Approvals (17080)
Artificial intelligence (260)
Autoimmune disease (20)
Automation (14)
Bankruptcy (389)
Best Places to Work (12287)
BIOSECURE Act (19)
Biosimilars (111)
Biotechnology (346)
Bladder cancer (65)
Brain cancer (27)
Breast cancer (268)
Cancer (2127)
Cardiovascular disease (184)
Career advice (2391)
Career pathing (32)
CAR-T (152)
Cell therapy (429)
Cervical cancer (20)
Clinical research (70008)
Collaboration (827)
Compensation (461)
Complete response letters (28)
COVID-19 (2801)
CRISPR (43)
C-suite (230)
Cystic fibrosis (104)
Data (2008)
Decentralized trials (2)
Denatured (28)
Depression (50)
Diabetes (267)
Diagnostics (6690)
Digital health (18)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (121)
Drug pricing (117)
Drug shortages (28)
Duchenne muscular dystrophy (92)
Earnings (88866)
Editorial (38)
Employer branding (23)
Employer resources (157)
Events (119927)
Executive appointments (684)
FDA (18261)
Featured Employer (56)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (732)
Gene editing (107)
Generative AI (23)
Gene therapy (316)
GLP-1 (789)
Government (4845)
Grass and pollen (5)
Guidances (48)
Healthcare (20183)
Huntington's disease (24)
IgA nephropathy (26)
Immunology and inflammation (124)
Indications (27)
Infectious disease (2943)
Inflammatory bowel disease (145)
Inflation Reduction Act (11)
Influenza (51)
Intellectual property (90)
Interviews (554)
IPO (17085)
IRA (49)
Job creations (4077)
Job search strategy (1975)
Kidney cancer (10)
Labor market (34)
Layoffs (514)
Leadership (19)
Legal (8722)
Liver cancer (76)
Lung cancer (311)
Lymphoma (137)
Machine learning (4)
Management (62)
Manufacturing (289)
MASH (68)
Medical device (14009)
Medtech (14014)
Mergers & acquisitions (20624)
Metabolic disorders (705)
Multiple sclerosis (76)
NASH (23)
Neurodegenerative disease (100)
Neuropsychiatric disorders (31)
Neuroscience (1994)
NextGen: Class of 2025 (7243)
Non-profit (4893)
Northern California (2482)
Now hiring (37)
Obesity (383)
Opinion (253)
Ovarian cancer (75)
Pain (87)
Pancreatic cancer (79)
Parkinson's disease (143)
Partnered (20)
Patents (216)
Patient recruitment (96)
Peanut (51)
People (62112)
Pharmaceutical (88)
Pharmacy benefit managers (19)
Phase I (21818)
Phase II (30731)
Phase III (22909)
Pipeline (1079)
Podcasts (87)
Policy (133)
Postmarket research (2932)
Preclinical (9362)
Press Release (70)
Prostate cancer (98)
Psychedelics (38)
Radiopharmaceuticals (263)
Rare diseases (394)
Real estate (6417)
Recruiting (72)
Regulatory (24070)
Reports (47)
Research institute (2581)
Resumes & cover letters (453)
Rett syndrome (3)
RNA editing (4)
RSV (43)
Schizophrenia (75)
Series A (130)
Series B (84)
Service/supplier (13)
Sickle cell disease (57)
Southern California (2162)
Special edition (17)
Spinal muscular atrophy (159)
Sponsored (31)
Startups (3905)
State (2)
Stomach cancer (16)
Supply chain (64)
The Weekly (57)
United States (22142)
Vaccines (738)
Venture capitalists (39)
Webinars (13)
Weight loss (272)
Women's health (36)
Worklife (18)
Date
Today (147)
Last 7 days (758)
Last 30 days (2912)
Last 365 days (35352)
2025 (8553)
2024 (37096)
2023 (41881)
2022 (53201)
2021 (57863)
2020 (56595)
2019 (49831)
2018 (37686)
2017 (34693)
2016 (34520)
2015 (40611)
2014 (34649)
2013 (29961)
2012 (31987)
2011 (32484)
2010 (30722)
Location
Africa (915)
Alabama (55)
Alaska (7)
Arizona (241)
Arkansas (14)
Asia (42631)
Australia (7737)
California (5734)
Canada (1905)
China (498)
Colorado (256)
Connecticut (271)
Delaware (134)
Europe (95233)
Florida (834)
Georgia (198)
Idaho (61)
Illinois (543)
India (24)
Indiana (300)
Iowa (10)
Japan (146)
Kansas (104)
Kentucky (26)
Louisiana (8)
Maine (60)
Maryland (879)
Massachusetts (4387)
Michigan (217)
Minnesota (389)
Mississippi (2)
Missouri (84)
Montana (30)
Nebraska (25)
Nevada (56)
New Hampshire (68)
New Jersey (1635)
New Mexico (31)
New York (1643)
North Carolina (1026)
North Dakota (7)
Northern California (2482)
Ohio (196)
Oklahoma (14)
Oregon (38)
Pennsylvania (1284)
Puerto Rico (10)
Rhode Island (29)
South America (1290)
South Carolina (18)
South Dakota (1)
Southern California (2162)
Tennessee (96)
Texas (854)
Utah (171)
Virginia (139)
Washington D.C. (63)
Washington State (540)
West Virginia (3)
Wisconsin (52)
753,548 Results for "tenax therapeutics formerly known as oxygen biotherapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Tenax Therapeutics Announces $25 Million Private Placement
March 5, 2025
·
3 min read
Press Releases
Tenax Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference
April 1, 2025
·
1 min read
Press Releases
Averna Therapeutics, formerly known as Exsilio Therapeutics, Appoints Thomas M. Barnes, Ph.D., as Chief Executive Officer
January 27, 2025
·
3 min read
Press Releases
Tenax Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
March 25, 2025
·
8 min read
Press Releases
Tenax Therapeutics to Participate in the Leerink Partners 2025 Global Healthcare Conference
March 3, 2025
·
1 min read
Press Releases
Tenax Therapeutics to Participate in the Guggenheim SMID Cap Biotech Conference
January 31, 2025
·
3 min read
Press Releases
Tenax Therapeutics Appoints Gillian Andor Vice President, Clinical Operations
January 22, 2025
·
4 min read
Bio NC
Tenax Therapeutics to Present at the 36th Annual Roth Conference
Tenax Therapeutics, Inc. today announced that it will participate in the 36th Annual Roth Conference in Dana Point, California, from March 17-19, 2024.
March 12, 2024
·
1 min read
Press Releases
Tenax Therapeutics Expands Phase 3 LEVEL Program, Advancing Two TNX-103 (Oral Levosimendan) Registrational Studies for the Treatment of PH-HFpEF
March 5, 2025
·
7 min read
Business
Tenax Therapeutics Reports First Quarter 2024 Financial Results and Provides a Corporate Update
Tenax Therapeutics, Inc. (Nasdaq: TENX), a Phase 3, development-stage pharmaceutical company focused on identifying, developing and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need, announced financial results for the first quarter of 2024 and provided a corporate update.
May 14, 2024
·
11 min read
1 of 75,355
Next
